Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.0001 0 (0%) Market Cap: 9,000.00 Enterprise Value: -17.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Infinity Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 07:00PM GMT
Release Date Price: $2.94 (+10.11%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team.

Our next presenting company is Infinity. And speaking on behalf of the company, we have CEO, Adelene Perkins. (Operator Instructions)

With that, I'll pass it over to you, Adelene.

Adelene Q. Perkins
Infinity Pharmaceuticals, Inc. - Chairman & CEO

Thank you, Anupam, and we can start with the slides. Thank you very much to JPMorgan for inviting Infinity Pharmaceuticals to present again this year and for all of you for listening to today's presentation.

It's a very important time at the company as we complete a data-rich 2020 and expect a data-rich 2021, starting with new data next month. There is a compelling investment thesis based on 4 data presentations over the past 2 months with eganelisib, our first-in-class immuno-oncology therapeutic with which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot